AAAAAA
Results:
1-7
|
Results: 7
Authors:
DETAKATS PG
DUNLOP D
KAYE SB
FYFE DW
BAKER P
PACCIARINI MA
VALOTA O
KERR DJ
Citation: Pg. Detakats et al., PHASE IB STUDY OF METHOXYMORPHOLINODOXORUBICIN (PNU-152243 FCE-23762)ADMINISTERED IN A 3 OR 4 WEEKLY SCHEDULE, European journal of cancer, 33, 1997, pp. 1133-1133
Authors:
JACOBS N
MAZZONI A
MEZZANZANICA D
NEGRI DRM
VALOTA O
COLNAGHI MI
MOUTSCHEN MP
BONIVER J
CANEVARI S
Citation: N. Jacobs et al., EFFICIENCY OF T-CELL TRIGGERING BY ANTI-CD3 MONOCLONAL-ANTIBODIES (MAB) WITH POTENTIAL USEFULNESS IN BISPECIFIC MAB GENERATION, Cancer immunology and immunotherapy, 44(5), 1997, pp. 257-264
Authors:
TOSI E
VALOTA O
CANEVARI S
ADOBATI E
CASALINI P
PEREZ P
COLNAGHI MI
Citation: E. Tosi et al., ANTIIDIOTYPIC RESPONSE TO ANTIGROWTH FACTOR-RECEPTOR MONOCLONAL-ANTIBODIES, European journal of cancer, 32A(3), 1996, pp. 498-505
Authors:
CASALINI P
MEZZANZANICA D
VALOTA O
ADOBATI E
TOMASSETTI A
COLNAGHI MI
CANEVARI S
Citation: P. Casalini et al., UNIDIRECTIONAL POTENTIATION OF BINDING BETWEEN 2 ANTI-FBP MABS - EVALUATION OF THE INVOLVED MECHANISMS, Journal of cellular biochemistry, 58(1), 1995, pp. 47-55
Authors:
TOSI E
VALOTA O
NEGRI DRM
ADOBATI E
MAZZONI A
MEAZZA R
FERRINI S
COLNAGHI MI
CANEVARI S
Citation: E. Tosi et al., ANTITUMOR EFFICACY OF AN ANTI-EPIDERMAL-GROWTH-FACTOR-RECEPTOR MONOCLONAL-ANTIBODY AND ITS F(AB')(2) FRAGMENT AGAINST HIGH-EGFR-EXPRESSING AND LOW-EGFR-EXPRESSING CARCINOMAS IN NUDE-MICE, International journal of cancer, 62(5), 1995, pp. 643-650
Authors:
NEGRI DRM
TOSI E
VALOTA O
FERRINI S
CAMBIAGGI A
SFORZINI S
SILVANI A
RUFFINI PA
COLNAGHI MI
CANEVARI S
Citation: Drm. Negri et al., IN-VITRO AND IN-VIVO STABILITY AND ANTITUMOR EFFICACY OF AN ANTI-EGFRANTI-CD3 F(AB')(2) BISPECIFIC MONOCLONAL-ANTIBODY, British Journal of Cancer, 72(4), 1995, pp. 928-933
Authors:
CANEVARI S
MIOTTI S
BOTTERO F
VALOTA O
COLNAGHI MI
Citation: S. Canevari et al., OVARIAN-CARCINOMA THERAPY WITH MONOCLONAL-ANTIBODIES, Hybridoma, 12(5), 1993, pp. 501-507
Risultati:
1-7
|